ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1367	National Cancer Institute	Html	en	Skin Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for skin cancer.	commonly occurring cancer 0.623357 skin cancer 0.936474 pediatric melanoma 0.671304 SCREEN study population 0.580579 skin awareness 0.580742 melanoma incidence rates 0.734128 observed modest mortality 0.599763 squamous cell cancers 0.595008 average annual incidence 0.632599 reduces melanoma mortality. 0.659883 health outcomes 0.587808 American Cancer Society 0.618195 important methodological limitations 0.577191 skin biopsy rates 0.677147 direct evidence 0.584321 nearly one-half 0.583908 two-stage skin cancer 0.6325 Medicare fee-for-service data 0.592604 U.S. cancer registries 0.618554 skin cancer screening 0.7411 melanoma 0.802792 UV radiation 0.57829 skin cancer awareness 0.703316 total-body visual examination 0.577539 vertical growth phase 0.58165	melanoma mortality rates 0.760008 reportable cancer 0.578136 End Results Program 0.589373 internal control group 0.578284 Basal cell carcinoma 0.600196 United States 0.662165 population-based skin cancer 0.635467 prolonged horizontal growth 0.582398 yearly incidence increase 0.63333 nonmelanoma skin cancers 0.683707 skin cancer. 0.5773 National Cancer Institute 0.614591 total number 0.59851 horizontal growth phase 0.661114 U.S. incidence rates 0.65648 main types 0.601467 initial pilot phase 0.579738 local disease 0.593927 skin lesions 0.583166 individual’s skin 0.577585 fewer melanoma death 0.654325 nonmelanoma skin cancer 0.723959 clinical visual screening 0.595993 SCREEN study 0.606378	CLICK HERE
1434	National Cancer Institute	Html	en	Chronic Lymphocytic Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.	CLL 0.563454 German CLL Study 0.551069 monoclonal B-cell lymphocytosis 0.528403 Engl J Med 0.555252 trial 0.525679 leukemia group 0.552678 M. Prolymphocytic leukemia 0.545972 Routine chronic administration 0.534661 lymphocytic leukemia patients 0.591222 Leukemia group B. 0.542105 CLL Study Group 0.54078 cyclophosphamide 0.529502 Byrd JC 0.527428 Keating MJ 0.535835 advanced chronic 0.539233 patients 0.592663 Lymphocytic Leukemia Study 0.593872 T-cell prolymphocytic leukemia 0.546745 refractory high-risk chronic 0.534243 refractory chronic 0.528565 Adult Leukemia Group 0.542021 Leuk Lymphoma 0.531402 Lymphocytic Leukemia section 0.595648 fludarabine 0.547348 alemtuzumab versus fludarabine 0.527105	untreated B chronic 0.530625 et al. 0.648755 treatment 0.535273 small lymphocytic lymphoma 0.590269 French Cooperative Group 0.528743 German Chronic Lymphocytic 0.583925 Relapsed Chronic Lymphocytic 0.579501 acute myeloid leukemia 0.53754 stem cell 0.529413 Leukemia Study Group 0.55235 rituximab 0.530116 fludarabine-refractory B-cell chronic 0.53547 CLL therapy 0.52689 chronic lymphoid leukemia 0.573599 CLL Study Group. 0.526303 Abstract 0.627578 therapy 0.53011 Clin Oncol 0.713099 hairy cell leukemia 0.553353 blood 0.56117 chronic lymphocytic leukemia 0.965039 chronic lymphocytic leukaemia 0.705583 previously untreated patients 0.578343 allogeneic stem cell 0.525551	CLICK HERE
1900	National Cancer Institute	Html	es	Tratamiento del cáncer de cuello uterino (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de cuello uterino.	siguientes procedimientos 0.302623 Estadios llB 0.300134 estadios lB1 0.300176 estadios ia 0.300186 estadio ivb 0.3015 cuello uterino.El estadio 0.301223 estadio iva 0.301104 proteína llamada factor 0.30017 estadios iiia 0.300186 recto.El cáncer 0.301048 áreas anormales.ampliar examen 0.300205 Instituto Nacional 0.300194 Cervical Cancer 0.300274 Drugs Approved 0.300299 pared pélvica.El cáncer 0.30107 medicamento des 0.300142 prueba pap 0.300163 principal factor 0.300454 siguientes estadios 0.300489 estadio lA1 0.300374 funcionar.El cáncer 0.301061 estadios iva 0.300174 prueba pap.ampliar 0.300132 pequeñas incisiones 0.30013 estadificación quirúrgica pretratamiento 0.300689	pequeña cantidad 0.300319 estadio ii 0.301571 estadio ia 0.301549 enlace drugs approved 0.300178 estadio ila 0.30036 realidad células 0.300277 estadio ia2 0.300842 cm.El estadio lB 0.300541 estadios iia 0.300188 estadio iiia 0.300822 PDQ Tratamiento 0.300222 estadio iia 0.300852 estadios ib1 0.300186 siguientes signos 0.300145 Physician Data Query 0.300387 Ampliar Cáncer 0.30485 siguientes causas 0.300199 lápiz mide 0.300224 estadio iii 0.301447 cuello uterino 0.99838 cono.La conización 0.30013 histerectomía abdominal 0.300165 estadio ib2 0.300835 siguientes sumarios 0.300269	CLICK HERE
1914	National Cancer Institute	Html	es	Tratamiento de los tumores del sistema nervioso central en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores del sistema nervioso central en adultos.	radiocirugía estereotáctica 0.512702 Organización Mundial 0.518554 gliomas mixtos 0.51602 Brain Tumors 0.505258 siguientes procedimientos 0.502302 adultos jóvenes 0.506123 siguientes aspectos 0.504348 faja ajustadora 0.507035 Turcot tipos 0.506804 siguientes afecciones 0.507417 carcinomas embrionarios 0.505469 células normales.ampliar exploración 0.504663 siguientes tipos 0.506796 rayos x 0.507888 Neurofibromatosis tipos 0.506813 encéfalo benignos 0.526234 enlace drugs approved 0.509464 carcinoma nevoide 0.505116	tumores benignos 0.543382 aparato explorador 0.50369 médula espinal.Tumores 0.528221 PDQ Tratamiento 0.597843 alta potencia 0.50285 tumores cerebrales 0.516865 saco vitelino 0.505401 siguientes factores 0.504592 sistema nervioso central 0.930279 menor daño 0.503236 cuerpo.ampliar exploración 0.504376 encéfalo.ampliar craneotomía 0.503787 von hippel-lindau 0.505069 tumores embrionarios 0.532834 cáncer.ampliar radioterapia 0.506826 radioterapia externa 3D 0.508073 radiocirugía estereotáxica 0.502266	CLICK HERE
1997	National Cancer Institute	Html	es	Tratamiento de los astrocitomas infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los astrocitomas infantiles.	high-grade astrocytoma 0.444609 BRAF mutation 0.44863 pontine gliomas 0.513199 brain tumors 0.449797 cerebellar astrocytomas 0.465185 astrocitomas pilocíticos 0.812488 Cancer Res 0.478751 thalamic gliomas from 0.475546 neurofibromatosis tipo 0.470126 pilocytic astrocytoma 0.928999 Children's Oncology Group 0.451226 optic-hypothalamic gliomas 0.471792 central nervous system 0.495263 gliomas reveals key 0.471536 h3f3a k27m mutation 0.438972 Nat Genet 0.454568 pediatric gliomas 0.555458 astrocitomas difusos).Recién 0.471123 Glioma Treated with 0.441082 Acta Neuropathol 0.692887 Pediatric Pilocytic Astrocytomas 0.43879 mutación braf v600e 0.473181 Organización Mundial 0.468352 Salud Grado 0.453036 Metastatic Low-Grade Gliomas 0.479197	braf v600e mutation 0.454684 astrocitomas infantiles grupo 0.489856 vía óptica 0.453436 Neuro Oncol 0.501948 BRAF V600E 0.638339 low-grade glioma 0.976552 Pediatr Blood Cancer 0.686119 gliomas with braf 0.498818 low-grade astrocytomas 0.452781 fusión braf-kiaa1549 0.457715 childhood low-grade glioma 0.438409 optic pathway glioma 0.455238 mutaciones braf v600e 0.497547 diffuse high-grade astrocytomas 0.440868 malignant gliomas arising 0.476149 Clin Oncol 0.452652 nervous system tumors 0.44069 sistema nervioso central 0.547399 gliomas identifies recurrent 0.476033 mutaciones braf 0.520493 mutaciones puntuales braf 0.489841 Saluda Tipo Grado 0.458304 presuntos gliomas 0.491024 Neuropathol Exp Neurol 0.51285	CLICK HERE
2005	National Cancer Institute	Html	es	Tratamiento de los tumores de estroma gastrointestinal (PDQ®)–Versión para pacientes	Información revisada por expertos sobre el tratamiento de los tumores de estroma gastrointestinal.	pequeñas incisiones 0.627953 siguientes procedimientos 0.660138 cuidado médico 0.818499 tubo gi.ampliar 0.664881 siguientes aspectos 0.645973 Neurofibromatosis tipo 0.638907 siguientes síndromes 0.651683 rayos x 0.707199 enlace drugs approved 0.645052 escáner tep 0.637347 ondas sonoras 0.640024 National Cancer Institute 0.620652 causarán signos 0.637878	siguientes riesgos 0.61572 Instituto Nacional 0.681879 PDQ Tratamiento 0.652674 siguientes problemas 0.648983 tubo gi 0.979564 Physician Data Query 0.683259 tumor mide 0.671706 PDQ Cánceres 0.69873 siguientes enlaces 0.62151 siguientes órganos 0.656962 siguientes pruebas 0.650191 Gastrointestinal Stromal Tumors 0.704979	CLICK HERE
3428	National Cancer Institute	Html	es	Terapia fotodinámica para el cáncer	Hoja informativa que explica en qué consiste la terapia fotodinámica, cómo se administra y las indicaciones y los efectos secundarios del tratamiento.	Molecular Biology 0.32441 photodynamic therapy 0.633479 photodynamic treatment 0.328771 Henderson BW 0.324256 Drug Administration 0.328891 causa efectos 0.325407 sustancia fotosensiblizadora 0.344827 Fukumura D 0.324644 Dongen GA 0.325062 Jain RK 0.326105 multidrug-resistant tumors 0.324624 porfímero sódico 0.914711 Snow GB 0.3246 luz solar 0.46733 sustancia fotosensibilizadora 0.526993	vías respiratorias 0.328731 Biomedical Science 0.324903 Dougherty TJ 0.324729 determinados tipos 0.331782 Reviews Cancer 0.32893 cabo estudios 0.366968 cuello uterino 0.325997 Capella LS 0.324402 PubMed Abstract 0.802286 medicamento fotosensibilizador 0.406789 Cancer Institute 0.326562 Pottier RH 0.324615 Visser GW 0.325175 Goyan RL 0.324518	CLICK HERE
3460	National Cancer Institute	Html	es	Coenzima Q10 (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de la coenzima Q10 como tratamiento para las personas con cáncer.	Natl Acad Sci 0.506232 animal models 0.503048 Lockwood K 0.522246 Friend leukemia virus 0.50335 Mol Aspects Med 0.525442 Prog Drug Res 0.505422 Exp Clin Res 0.507107 Ernster L 0.506157 Clin Investig 0.504327 vitamina q10 0.508703 vitamin q10 0.549224 Health Syst Pharm 0.503499 Chem Pathol Pharmacol 0.515808 Bliznakov EG 0.512562 Hanioka T 0.504235 coenzyme q10 0.845306 with vitamin q10 0.522905 reticuloendothelial system upon 0.50329 Res Commun Chem 0.525595 coenzima q10 0.990386 Nylander M 0.503126 system upon stimulation 0.503357 coenzima q.10 0.50372 Coenzyme Q10 administration 0.515239 patients with 0.52239	Clinical Aspects 0.506167 Folkers K 0.720923 patients treated with 0.503528 Osterborg A 0.503093 coenzima q10 resumen 0.509859 Commun Chem Pathol 0.52121 Moesgaard S 0.509545 Biophys Res Commun 0.66246 Chemother Rep 0.503476 Nordenbrand K 0.502764 Proc Natl Acad 0.506461 Apparent partial remission 0.503092 Biochem Biophys Res 0.653978 with nutritional antioxidants 0.504649 coenzima q10 ayuda 0.51293 Drugs Exp Clin 0.50459 conzima q10 0.506965 Overvad K 0.504381 Clin Nutr 0.503026 serious deficiency 0.503488 coenzyme q10 concentrations 0.523415 radicales libres 0.504036 essential fatty acids 0.503269 Yamashita S 0.503124	CLICK HERE
3769	National Cancer Institute	Html	es	Medicina de precisión en el tratamiento del cáncer	Información sobre el papel que tiene la medicina de precisión en el tratamiento del cáncer.	precisión para tratamiento 0.796037 máquina llamada secuenciador 0.682468 cuáles cambios 0.881741 cuáles tratamientos funcionarán 0.880419 que los pacientes 0.633734	campo de investigación 0.604701 seguro médico 0.550546 cáncer el cambio 0.9829 responda el tumor 0.621072 a cuáles tratamientos 0.724195	CLICK HERE
16842	National Cancer Institute	Html	en	Johns Hopkins University — Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer Research	The focus of the Johns Hopkins University Cancer Nanotechnology Training Center is presented here.	predoctoral fellows 0.736483 cancer nanobiotechnology 0.632531 optimal treatment 0.545276 Johns Hopkins University 0.729715 journal club 0.539106 novel cancer diagnostics 0.713403 program fosters 0.562779 steady state number 0.670018 epigenetic markers 0.560601 tumor boards 0.538166 NTCR program 0.576419 new frontier 0.564875 individual patient 0.643505 engineering/physics discipline 0.563571 physical sciences-oncology center 0.676488 lab course 0.540911 new modalities 0.563 cellular / cancer 0.59221 Johns Hopkins Institute 0.669855 dedicated annual symposium 0.651728 experimental facilities 0.538368 Vivo Cellular 0.548936 Molecular Imaging Center 0.688968 black-box input-output techniques 0.710638	scientific exploration 0.554225 clinical resources 0.5443 human diseases 0.555299 cancer cell functions 0.720912 clinical conferences 0.540551 high-throughput diagnostic tools 0.682779 non-viral delivery systems 0.686087 unique educational resources 0.657197 postdoctoral fellows 0.715577 Principal Investigator 0.564913 therapeutic tools 0.551025 Pancreatic Cancer Center 0.731915 Ludwick Center 0.581555 NTCR trainees 0.59515 cancer nanotechnology excellence 0.742492 outstanding trainees 0.578764 disease phenotype 0.55677 Comprehensive Cancer Center 0.727928 Cancer Genetics 0.585039 NTCR fellows 0.742981 engineer novel drug/antibody/siRNA 0.668859 human cancers 0.551276 core courses 0.541397 Training Focus 0.565904	CLICK HERE